CII
STML

CR Intrinsic Investors’s Stemline Therapeutics, Inc. STML Stock Holding History

CR Intrinsic Investors’s Portfolio STML Stock Details STML Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-76,308
Closed -$3.46M – 366
2013
Q3 		$3.46M Buy
+76,308
New +$3.46M 0.11% 219